article thumbnail

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report 

Cardiometabolic Health Congress

The 2024 report from the Lancet Standing Commission on Dementia Prevention, Intervention, and Care brings promising developments for healthcare professionals and public health advocates. The Takeaway The 2024 Lancet Commission report is a call to action for healthcare providers and public health advocates.

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research , in a statement issued by the FDA. Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health.” 2 What is Wegovy? 10,11 In the U.S.,

Obesity 111